For pharmacovigilance teams

Stop losing days to literature screening, and stop missing cases.

Screenoma searches the literature for your products every day, removes duplicates, and pre-checks each possible case against the ICSR minimum criteria with quoted evidence. Your reviewers decide in one click, with a full record of who decided what.

Tell us your setupSee it on sample data →

Paid plans from $290/month · no setup fee · cancel any time

AI ICSR queue · sample data

PubMed + Europe PMC AI Valid ICSR 0.93Acute pancreatitis after initiation of [Sample drug A]: a case report✓ Identifiable patient · ✓ Identifiable reporter · ✓ Suspect product · ✓ Adverse event
Europe PMC (preprint) AI Not an ICSR 0.81Hepatic enzyme elevations in a cohort treated with [Sample drug A]✗ Identifiable patient · ✓ Identifiable reporter · ✓ Suspect product · ✓ Adverse event
Crossref AI Needs human review 0.62Severe hypoglycaemia in an elderly patient on [Sample drug A] and a sulfonylurea✓ Identifiable patient · ✓ Identifiable reporter · ? Suspect product · ✓ Adverse event

The problem

Literature monitoring is a legal duty that runs on spreadsheets

Hours lost every week

Someone on your team runs the same searches, reads hundreds of abstracts and copies results into a spreadsheet, every week, for every product.

Cases slip through

Brand names, misspellings, local journals and preprints get missed, and the same case appears in several articles.

The clock is already running

Day 0 starts when an article meets the minimum criteria: 15 days for serious and 90 days for non-serious ICSRs in the EU. Late screening eats that time.

Questions you cannot answer

What did you search, when, and who decided what and why? A spreadsheet rarely answers all of that.

Is this you?

Tick what applies. Two or more and we are probably worth a 20-minute call.

What changes

Outcomes, not features

Hours back every week

Daily searches of PubMed, Europe PMC (incl. preprints), OpenAlex and Crossref run themselves for every product and synonym. Your team reviews a short, ranked queue instead of raw search results.

Fewer missed cases

Brand names, synonyms, preprints and broad indexes are searched together; duplicates across sources are merged so each article is reviewed once.

Faster, consistent triage

The Corvus Engine checks patient, reporter, suspect product and adverse event, quotes the evidence and extracts case details, so reviewers confirm instead of reading from scratch, and day 0 is caught early.

Complete record

What was searched and when, every engine output, every decision with who, when and why, e-signed and versioned, plus a weekly report.

How the Corvus Engine works

From new papers to signed ICSR decisions

The engine behind Screenoma. It does the searching and first-pass case assessment so your qualified reviewers spend their time deciding, not reading.

1

Gather

Every product and its brand names and synonyms is searched daily across PubMed, Europe PMC (including preprints), OpenAlex and Crossref, plus Embase, Scopus and other paid databases on your own licence.

2

Merge

The same paper found in several places is merged into one record, and articles already seen are not shown again, so each one is reviewed once.

3

Assess

Each relevant article is checked against the four minimum ICSR criteria: identifiable patient, identifiable reporter, suspect product and adverse event. Every criterion comes with a quote from the text, plus a proposed decision, a confidence score and extracted case details such as seriousness and outcome when stated.

4

Decide

In Assist mode the engine proposes and your reviewer decides. On Professional, Full auto applies only clear, high-confidence results and sends anything uncertain to a person.

5

Learn and record

Your team’s signed decisions and overrides for a product guide the engine’s future checks for that product, for your organisation only. Every search run, engine output and e-signed, versioned decision goes into a tamper-evident audit trail.

The engine supports decisions and can be wrong. A qualified person stays responsible, and anything unclear goes to a human.

Savings example

What 5 products cost to monitor each month

In-house team

≈ ₹38,000 / month

Estimate: about 3 hours of screening per product per week plus 1 hour of senior QC, at a typical Indian drug safety associate salary (median ₹3.85 lakh a year1, plus employment overheads).

Outsourced vendor

₹27,000–55,000 / month

Published vendor rates are roughly ₹5,400–11,000 per product per month2,3.

Screenoma Starter + your review

≈ ₹26,000 / month

₹14,900 plan, plus an estimated ₹11,000 of qualified reviewer time, because a person still checks what the AI proposes.

At 20 products

₹1,995 per product a month

on Professional, against roughly ₹5,400–11,000 per product from a vendor.

Example estimate, not measured customer data; your numbers will vary. Sources: 1 PayScale India, 2026 · 2 The Pharma Partner (KES 8–15k/product) · 3 SafePhV benchmark (£18k/yr for 15 products). Currency converted at approximate rates.

Built on how literature monitoring actually works

How Screenoma covers the literature

Every day

Screenoma screens daily and keeps a dated log of each search.

Local journals count

Local journals in countries where your products are sold matter too. OpenAlex and Crossref widen coverage beyond biomedical indexes; regional sources can be added with you.

Duplicates are real

The same patient can appear in several articles and sources. Articles are merged across sources and flagged for reviewers so one case is not reported twice.

Four minimum criteria

A valid ICSR needs an identifiable patient, an identifiable reporter, a suspect product and an adverse reaction. Each is checked with a quote from the text.

Bring your own licence

Already licensed for Embase (or other paid databases)? Connect your own licence (API access required) and Screenoma screens it too: available on request. Paid databases are not included in plans and are not integrated today; we set each one up with you using your licence.

EmbaseScopusWeb of ScienceBIOSIS PreviewsOvid (MEDLINE / Embase)ProQuest DialogEBSCO (CINAHL)CortellisOther licensed databases or local / regional journals

Ask about your licence

Straight talk

What Screenoma does not do, and when it is not a fit

AI does not replace your experts

AI suggests; qualified people decide. Assist mode (human sign-off) is the default and what we recommend. Full auto is optional and only applies confident, unambiguous decisions; your company stays responsible for case validity and reporting.

Paid databases need your licence

Embase, Scopus, Web of Science and similar are not included. If you have a licence with API access, we connect it with you; without one we search PubMed, Europe PMC (incl. preprints), OpenAlex and Crossref only.

Not a safety database

We find, screen and triage literature. Case processing, MedDRA coding and E2B submission stay in your safety database.

How buying works

Five steps, no surprises

1

Fit call (20 min)

We learn your products, markets, current process and pain. If we are not a fit, we say so and point you elsewhere.

2

Demo on your products

We run Screenoma on two or three of your real products so your team judges real output, not slides.

3

IT & security review

Your IT team reviews how the service works, where data is hosted and our service providers.

4

Contract & payment

Monthly plan via Razorpay, or an order form for Enterprise. No setup fee, cancel any time.

5

Onboarding

Products, synonyms and search strategy set up with you in week one; first screen the same day.

Who is usually involved: the head of safety (signs off the approach), PV operations (daily users), IT (security review) and procurement (contract). We can brief each of them directly.

Pricing

Priced per product monitored

US dollars, charged as the equivalent in INR. No free plan or trial; the demo shows sample data.

Enterprise

from $2,490 (₹1,49,000) / month

Annual contract

Unlimited products. For large portfolios and global safety teams.

  • Everything in Professional
  • Single sign-on, unlimited users
  • Hands-on setup support
  • 4-hour response, uptime commitment in contract
  • Custom connectors and regional sources
  • Named contact
Book a fit call

Recommended

Professional

$690 (₹39,900) / month

= $35 (₹1,995) per product per month

or $6,900 (₹3,99,000) / year: 2 months free

Up to 20 products. End-to-end AI ICSR confirm / reject.

  • Corvus Engine: Assist and Full auto modes
  • Electronic signatures, tamper-evident audit trail
  • Search log and literature reports
  • Guided onboarding included
  • Bring your own licence: Embase, Scopus, Web of Science and more
  • 10 users · reply next business day
  • Add 5 products for $190 (₹9,900) / month
Subscribe monthlySubscribe yearly

Starter

$290 (₹14,900) / month

= $58 (₹2,980) per product per month

Up to 5 products. AI suggests, your reviewer decides.

  • Assist mode only (no Full auto)
  • Daily search: PubMed, Europe PMC (incl. preprints), OpenAlex and Crossref
  • Corvus Engine ICSR assessment with quoted evidence
  • Standard audit log and weekly report
  • 2 users · reply within 2 business days
  • No paid-database connectors
Subscribe

Prices in US dollars for reference; you are charged the rupee amount shown in brackets (your card issuer converts). Renews automatically each month (or year), cancel any time from your account. No free plan or trial; the demo shows sample data. Fair use: up to 2,000 articles per product per month. To add product packs, tell us and we add them to your subscription.

Founding customers: the first 10 customers keep their price for 24 months.

Already a customer? Customer login. Paid databases are searched only on your own licence (API access required). See the list.

Best for

  • Small and mid-size MAHs, generics and CROs with 1–25 products
  • Teams screening literature manually or paying per-hour vendor fees
  • Teams who want a documented, auditable weekly screen

Not for

  • Teams wanting fully unsupervised AI case decisions
  • Portfolios over 100 products without a scoping call (see Enterprise)

After you pay

What happens next

Day 0

Payment confirmed, sign-in set up, first product added and its last 30 days screened and AI-assessed within minutes.

Week 1 checklist

  • All products and synonyms (INN, brands, codes)
  • Search strategy reviewed and documented
  • Reviewers, roles and AI mode agreed
  • Embase/other licence connected if you have one

Every month

A short review with you: what was found, decisions made, AI disagreements and anything to tune. You can cancel any time and export everything.

Fair questions

Concerns we hear, answered honestly

“It is too expensive.”

Fair: budgets in PV are tight. Compare it with the hours your team or vendor spends on screening and first-pass triage each month; the example above shows how the maths can work, but use your own numbers. If you only monitor one or two products with very little literature, manual screening may honestly be cheaper.

“What about data privacy?”

Understandable. Searches contain product names, not personal data; articles are published literature. Account data is minimal and hosted on Cloudflare; see our privacy policy.

“Our vendor already does this.”

Then you already know the value. The questions are cost per month, how quickly cases reach you, and whether you can see the search strategy and audit trail yourself. Some teams run Screenoma alongside a vendor for a month to compare. If your vendor serves you well, keep them.

“Switching sounds like effort.”

Most of the effort is listing products and synonyms. We do it with you in week one, screen the last 30 days the same day, and you can run in parallel with your current process until you are confident.

“Can the AI be trusted?”

It can be wrong, and model confidence is not measured accuracy. That is why Assist mode is the default, anything unclear goes to a human, and every Corvus Engine output is logged with its engine version.

“Is there a free plan or trial?”

No. Plans are paid from day one and you can cancel any time. To see real output on your products before buying, ask for a demo on the fit call.

Tell us your setup

Two minutes. We reply within one working day to book a 20-minute fit call. If Screenoma is not the right tool, we will say so.

Stored only to reply to you. See our Privacy Policy.

Decision support only. Screenoma is decision-support software for literature screening and AI-assisted ICSR triage. Automated triage and AI assessment can miss or misclassify articles; your company and its qualified users remain responsible for reviewing the literature and for all case reporting decisions.